Expression of COX-2, CD44v6 and CD147 and Relationship with Invasion and Lymph Node Metastasis in Hypopharyngeal Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yang, Qing ^a   Liu, Yehai ^a   Huang, Yang ^a   Huang, Dake ^a   Li, Yifan ^a   Wu, Jing ^a   Duan, Maoli ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CD44V6 ANTIGEN; CYCLOOXYGENASE 2; FORMALDEHYDE; PARAFFIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHINESE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIMARY TUMOR; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; TUMOR INVASION; TUMOR RECURRENCE;

ANTIGENS, CD147; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883435697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071048     Document Type: Article

References (31)

1. Hall SF, Groome PA, Irish J, O'Sullivan B, (2008) The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope118(8): 1362-1371.
2. Berrino F, Gatta G, (1998) Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. Eur J Cancer34(14): 2154-2161.
3. Grandis JR, Pietenpol JA, Greenberger JS, Pelroy RA, Mohla S, (2004) Head and neck cancer: meeting summary and research opportunities. Cancer Res 64(21): 8126-8129.
4. Prescott SM, Fitzpatrick FA, (2000) Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta1470(2): 69-78.
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, et al. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107(4): 1183-1188.
6. Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimaki A, et al. (2008) Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 100(6): 421-427.
7. Bin W, He W, Feng Z, Xiangdong L, Yong C, et al. (2011) Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer. Acta Histochem 113(2): 131-136.
8. Li F, Liu Y, Chen H, Liao D, Shen Y, et al. (2011) EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features. J Exp Clin Cancer Res30: 27.
9. Kyzas PA, Stefanou D, Agnantis NJ, (2005) COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol18(1): 153-160.
10. Scheer M, Drebber U, Breuhahn K, Mockel C, Reuther T, et al. (2010) Expression of cyclooxygenase-2 (COX-2) in an advanced metastasized hypopharyngeal carcinoma and cultured tumor cells. Oral Maxillofac Surg 14(1): 53-57.
11. Yu P, Zhou L, Ke W, Li K, (2010) Clinical significance of pAKT and CD44v6 overexpression with breast cancer. J Cancer Res Clin Oncol 136(8): 1283-1292.
12. Zlobec I, Gunthert U, Tornillo L, Lezzi G, Baumhoer D, et al. (2009) Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Histopathology 55(5): 564-575.
13. Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, et al. (2009) CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep 22(4): 745-755.
14. Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, et al. (2001) Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 158(6): 1921-1928.
15. Rosenthal EL, Shreenivas S, Peters GE, Grizzle WE, Desmond R, et al. (2003) Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope 113(8): 1406-1410.
16. Huang Z, Huang H, Li H, Chen W, Pan C, (2009) EMMPRIN expression in tongue squamous cell carcinoma. J Oral Pathol Med 38(6): 518-523.
17. Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, et al. (2002) Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res22(4): 2089-2096.
18. Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M, et al. (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33(7): 708-714.
19. Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, et al. (2001) Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 276(24): 20809-20812.
20. Heider KH, Sproll M, Susani S, Patzelt E, Beaumier P, et al. (1996) Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas. Cancer Immunol Immunother 43(4): 245-253.
21. Nozoe T, Kohnoe S, Ezaki T, Kabashima A, Maehara Y, (2004) Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol130(6): 334-338.
22. Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, et al. (2004) Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 31(1): 35-41.
23. Kunishi M, Kayada Y, Yoshiga K, (1997) Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg 26(4): 280-283.
24. Rodrigo JP, Dominguez F, Alvarez C, Gonzalez MV, Herrero A, et al. (2002) Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx. Am J Clin Pathol 118(1): 67-72.
25. Guler G, Sarac S, Uner A, Karabulut E, Ayhan A, et al. (2002) Prognostic value of CD44 variant 6 in laryngeal epidermoid carcinomas. Arch Otolaryngol Head Neck Surg 128(4): 393-397.
26. Mack B, Gires O, (2008) CD44s and CD44v6 expression in head and neck epithelia. PloS One 3(10): e3360.
27. Erdem NF, Carlson ER, Gerard DA, Ichiki AT, (2007) Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. J Oral Maxillofac Surg 65(9): 1725-1733.
28. Huang C, Sun Z, Sun Y, Chen X, Zhu X, et al. (2012) Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathology 60(5): 793-803.
29. Sikorska B, Danilewicz M, Wagrowska-Danilewicz M, (2002) Prognostic significance of CD44v6 and nm23 protein immunoexpression in laryngeal squamous cell carcinoma. Pol J Pathol 53(1): 17-24.
30. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, et al. (1995) CD44 variant ex on epitopes in primary breast cancer and length of survival. Lancet 345(8950): 615.
31. Quemener C, Gabison EE, Nai{dotless}mi B, Lescaille G, Bougatef F, et al. (2007) Extracellular matrix metalloproteinase inducer up-regulates the uroki-nase-type plasminogen activator system promoting tumor cell invasion. Cancer Res 67: 9-15.